A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus

@inproceedings{Liu2013APE,
  title={A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus},
  author={Xuebin Liu and Pei Chun Zheng and Xiaodong Wang and Guang-Hui Dai and Hongbin Cheng and Zan Zhang and Rongrong Hua and Xinxin Niu and Jing Shi and Yi-hua An},
  booktitle={Stem Cell Research & Therapy},
  year={2013}
}
Stem cell therapy has recently been introduced to treat patients with type 2 diabetes mellitus (T2DM). However, no data are available on the efficacy and safety of allogeneic Wharton’s Jelly-derived mesenchymal stem cell (WJ-MSC) transplantation in patients with T2DM. Here we performed a non-placebo controlled prospective phase I/II study to determine efficacy and safety of WJ-MSC transplantation in T2DM. Twenty-two patients with T2DM were enrolled and received WJ-MSC transplantation through… CONTINUE READING